The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression
Abstract
Systemic lupus erythematosus is a complex autoimmune disease characterized by dysregulated interactions between autoreactive T and B lymphocytes and the development of anti-nuclear Abs. The recently described pleiotropic cytokine IL-21 has been shown to regulate B cell differentiation and function. IL-21 is produced by activated T lymphocytes and its interactions with IL-21R are required for isotype switching and differentiation of B cells into Ab-secreting cells. In this report, we studied the impact of blocking IL-21 on disease in the lupus-prone MRL-Faslpr mouse model. Mice treated for 10 wk with IL-21R.Fc fusion protein had reduced proteinuria, fewer IgG glomerular deposits, no glomerular basement membrane thickening, reduced levels of circulating dsDNA autoantibodies and total sera IgG1 and IgG2a, and reduced skin lesions and lymphadenopathy, compared with control mice. Also, treatment with IL-21R.Fc resulted in a reduced number of splenic T lymphocytes and altered splenic B lymphocyte ex vivo function. Our data show for the first time that IL-21 has a pathogenic role in the MRL-Faslpr lupus model by impacting B cell function and regulating the production of pathogenic autoantibodies. From a clinical standpoint, these results suggest that blocking IL-21 in systemic lupus erythematosus patients may represent a promising novel therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B., & Dixon, F. J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.5.1198 · Cited by 1,598
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978
Inhibition of Th1 Development Mediated by GATA-3 through an IL-4-Independent Mechanism
Ouyang, W., Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L., Sha, W. C., & Murphy, K. M. (1998) · Immunity · doi:10.1016/s1074-7613(00)80671-8 · Cited by 778
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Ozaki, K., Spolski, R., Ettinger, R., Kim, H.-P., Wang, G., Qi, C.-F., Hwu, P., Shaffer, D. J., Akilesh, S., Roopenian, D. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5361 · Cited by 668
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Etiopathogenesis of Murine SLE1
THEOFILOPOULOS, A. N., & Dixon, F. J. (1981) · Immunological Reviews · doi:10.1111/j.1600-065x.1981.tb00343.x · Cited by 511
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
Self-citationInterleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation
Leonard, W. J., & Spolski, R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1688 · Cited by 441
The role of B cells in lpr/lpr-induced autoimmunity.
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M., & Huszar, D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1295 · Cited by 361
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.
Balomenos, D., Rumold, R., & Theofilopoulos, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci750 · Cited by 356
Cutting Edge: IL-21 Is a Switch Factor for the Production of IgG1 and IgG3 by Human B Cells
Pène, J., Gauchat, J.-F., Lécart, S., Drouet, E., Guglielmi, P., Boulay, V., Delwail, A., Foster, D., Lecron, J.-C., & Yssel, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5154 · Cited by 315
Chan, O., & J. Shlomchik, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.51 · Cited by 306
Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Del Vecchio Blanco, G., Caruso, R., Tersigni, R., Alessandroni, L., Biancone, L., Naccari, G. C., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.042 · Cited by 293
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
Wurster, A. L., Rodgers, V. L., Satoskar, A. R., Whitters, M. J., Young, D. A., Collins, M., & Grusby, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020620 · Cited by 274
Self-citationMoroz, A., Eppolito, C., Li, Q., Tao, J., Clegg, C. H., & Shrikant, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.900 · Cited by 268
Jin, H., Carrio, R., Yu, A., & Malek, T. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.657 · Cited by 254
Vlahakos, D., Foster, M. H., Ucci, A. A., Barrett, K. J., Datta, S. K., & Madaio, M. P. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v281345 · Cited by 241
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang, G., Tschoi, M., Spolski, R. J., Lou, Y., Ozaki, K., Feng, C., Kim, G., Leonard, W. J., & Hwu, P. (2003) · PubMed · Cited by 221
Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites
Vlahakos, D. V., Foster, M. H., Adams, S., Katz, M., Ucci, A. A., Barrett, K. J., Datta, S. K., & Madaio, M. P. (1992) · Kidney International · doi:10.1038/ki.1992.242 · Cited by 216
Haas, C., Ryffel, B., & Hir, M. L. (1998) · PubMed · Cited by 209
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
Jevnikar, A. M., Grusby, M. J., & Glimcher, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1137 · Cited by 188
[42] Selection and coamplification of heterologous genes in mammalian cells
Kaufman, R. J. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85044-o · Cited by 182
Haas, C., Ryffel, B., & Le Hir, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3713 · Cited by 180
[39] Vectors used for expression in mammalian cells
Kaufman, R. J. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85041-l · Cited by 174
Ma, H.-L., Whitters, M. J., Konz, R. F., Senices, M., Young, D. A., Grusby, M. J., Collins, M., & Dunussi-Joannopoulos, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.608 · Cited by 162
Self-citationOkamura, M., Kanayama, Y., Amastu, K., Negoro, N., Kohda, S., Takeda, T., & Inoue, T. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.1.14 · Cited by 158
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
Vollmer, T. L., Liu, R., Price, M. A., Rhodes, S. N., Cava, A. L., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2696 · Cited by 137
Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells
Koh, D., Ho, A., Rahemtulla, A., Fung‐Leung, W., Griesser, H., & Mak, T. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250923 · Cited by 137
IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responses
Habib, T., Nelson, A., & Kaushansky, K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.039 · Cited by 127
Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance
Steurer, W., Nickerson, P. W., Steele, A. W., Steiger, J. U., Zheng, X. X., & Strom, T. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1165 · Cited by 124
Reininger, L., Berney, T., Shibata, T., Spertini, F., Merino, R., & Izui, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.10038 · Cited by 116
New treatments for SLE: cell-depleting and anti-cytokine therapies
Anolik, J. H., & Aringer, M. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.05.006 · Cited by 101
Lenda, D. M., Stanley, E. R., & Kelley, V. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4744 · Cited by 89
Tumour necrosis factor and other cytokines in murine lupus
Theofilopoulos, A. N., & Lawson, B. R. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i49 · Cited by 85
β2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice
Christianson, G. J., Blankenburg, R. L., Duffy, T. M., Panka, D. J., Roths, J. B., Marshak‐Rothstein, A., & Roopenian, D. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4932 · Cited by 81
Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice.
Slack, J. H., Hang, L., Barkley, J., Fulton, R. J., D'Hoostelaere, L. A., Robinson, A. P., & Dixon, F. J. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1271 · Cited by 79
Bijl, M., Dijstelbloem, H. M., Oost, W. W., Bootsma, H., Derksen, R. H. W. M., Aten, J., Limburg, P. C., & Kallenberg, C. G. M. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.1.62 · Cited by 61
Furukawa, F., Kanauchi, H., Wakita, H., Tokura, Y., Tachibana, T., Horiguchi, Y., Imamura, S., Ozaki, S., & Takigawa, M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12298305 · Cited by 54
IL-21 and IL-21 Receptor: A New Cytokine Pathway Modulates Innate and Adaptive Immunity
Collins, M. A., Whitters, M. J., & Young, D. A. (2003) · Immunologic Research · doi:10.1385/ir:28:2:131 · Cited by 52
Self-citationThe Role of Host (Endogenous) T Cells in Chronic Graft-Versus-Host Autoimmune Disease
Chen, F., Maldonado, M. A., Madaio, M. P., & Eisenberg, R. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5880 · Cited by 52
New therapies for systemic lupus erythematosus
Goldblatt, F., & Isenberg, D. A. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02795.x · Cited by 50
Caven, T. H., Shelburne, A. E., Sato, J., Yee, C.-L., Becker, S., & Conrad, D. H. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2006.03.001 · Cited by 45
Cited by
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
Vinuesa, C. G., Linterman, M. A., Yu, D., & MacLennan, I. C. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055605 · Cited by 1,141
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
Spolski, R., & Leonard, W. J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090316 · Cited by 696
Metadata
- Authors
- Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M., & Dunussi-Joannopoulos, K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03
- Volume
- 178
- Issue
- 6
- Pages
- 3822-3830
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2165470016
- Cited by
- 298
- References
- 48
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.